Calamos Advisors LLC acquired a new stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 12,937 shares of the company’s stock, valued at approximately $329,000. Several other large investors have […]